Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invent Medic Sweden ABXSAT:IMS +0.55% EV-to-EBIT is -3.89 as of Aug. 15, 2026. The stock has 2 warning signs investors should review. Among 473 Medical Devices & Instruments companies, Invent Medic Sweden AB ranks worse than 211416.28% on this metric.
The historical rank and industry rank for Invent Medic Sweden AB's EV-to-EBIT or its related term are showing as below:
XSAT:IMS'
s EV-to-EBIT Range Over the Past 10 Years
Min: -18.9 Med: -3.28 Max: 0.09
Current: -3.89
During the past 10 years, the highest EV-to-EBIT of Invent Medic Sweden AB was 0.09. The lowest was -18.90. And the median was -3.28.
XSAT:IMS's EV-to-EBIT is ranked worse than 100% of 473
companies
in the Medical Devices & Instruments industry
Industry Median: 19.17
vs XSAT:IMS: -3.89
Invent Medic Sweden AB (XSAT:IMS) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Invent Medic Sweden AB's Enterprise Value for the quarter that ended in Mar. 2026 was kr21.79 Mil.
Invent Medic Sweden AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-4.40 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Invent Medic Sweden AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invent Medic Sweden AB EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Invent Medic Sweden AB's EV-to-EBIT falls into.
Invent Medic Sweden AB's current Enterprise Value is kr17.11 Mil.
Invent Medic Sweden AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-4.40 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invent Medic Sweden AB (XSAT:IMS) has a EV-to-EBIT of -3.89 as of Aug. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Invent Medic Sweden AB and its competitors. According to the industry distribution chart, Invent Medic Sweden AB ranks #999999 out of 473 companies in the Medical Devices & Instruments industry.
Is Invent Medic Sweden AB's EV-to-EBIT too high?
Invent Medic Sweden AB's current EV-to-EBIT is -3.89. Based on the distribution chart, Invent Medic Sweden AB ranks #999999 out of 473 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Invent Medic Sweden AB's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Invent Medic Sweden AB ranks #999999 out of 473 companies for EV-to-EBIT. This places Invent Medic Sweden AB in the lower half of its industry. The industry median EV-to-EBIT is 19.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.17, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Invent Medic Sweden AB and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invent Medic Sweden AB's current EV-to-EBIT is -3.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invent Medic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Invent Medic Sweden AB (XSAT:IMS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr0.18, compared to a current price of kr0.09 — trading 48.9% below its estimated fair value. The current EV-to-EBIT is -3.89. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Invent Medic Sweden AB (XSAT:IMS), the current EV-to-EBIT is -3.89 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:IMS has been successfully added to your 
